Luis Zeichner (Ostrosky-Zeichner) Ostrosky MD FACP, FIDSA, FSHEA, FECMM
Healthcare Associated Infections, Transplant/Immunocompromised States
Professor and chief, Memorial Hermann Endowed Chair, Division of Infectious Diseases, University of Texas Medical School at Houston
Join to View Full Profile
6431Fannin StMSB 2112.FHouston, TX 77030
Phone+1 713-500-6733
Fax+1 713-500-5495
Dr. Ostrosky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Professor of medicine and epidemiology, Memorial Hermann Endowed Chair, Vice-Chair of Medicine, Director, Laboratory of Mycology Research, Division Chief, Infectious Diseases, UTHealth. Chief Epidemiology Officer, Memorial Hermann. Senior Editor, Journal of Antimicrobial Chemotherapy. Assoc. Editor, Clinical Infectious Diseases. Past-President of the Mycoses Study Group. Consultant, FDA and CDC.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 1999 - 2002
U Texas Med Sch1999 - 2002
Universidad Nacional Autonoma de MexicoClass of 1995, Honors
Certifications & Licensure
TX State Medical License 2002 - 2026
American Board of Medical QualityCMQ
Awards, Honors, & Recognition
- Fellow European Confederation of Medical Mycology
- Fellow American College of Physicians
- Fellow Infectious Diseases Society of America
- Join now to see all
Clinical Trials
- Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU) Start of enrollment: 2007 Aug 01
- Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment Start of enrollment: 2017 Apr 01
- CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- Fungal meningitis in U.S. Patients who Received Epidural Anesthesia in Matamoros, Mexico.Dallas J Smith, Elizabeth Misas, Jeremy A W Gold, Nicole Evert, Thi Dang
Clinical Infectious Diseases. 2025-07-22 - Invasive Fungal Disease in Solid Organ and Hematopoietic Cell Transplant Recipients, United States.Jeremy A W Gold, Kaitlin Benedict, Elizabeth Sajewski, Tom Chiller, Meghan Lyman
Transplant Infectious Disease. 2025-07-08 - COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergil...M Hong Nguyen, Sixto M Leal, Luis Ostrosky-Zeichner, Andrej Spec, George R Thompson
Open Forum Infectious Diseases. 2025-07-01
Authored Content
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Accuracy of the NHSN Central Line-Associated Bloodstream Infection DefinitionOctober 2018
- IDWeek 2018: Using Blockchain to Develop a Novel Propensity Score for Candidemia and Invasive CandidiasisOctober 2018
Press Mentions
An Infectious Disease Physician Is Available to Discuss the Increase in COVID-19 Infections in TexasAugust 14th, 2025- COVID-19 Is Rising Again. Here’s What to KnowJuly 24th, 2025
- Lessons Learned: Fungal Meningitis Outbreak After Mommy MakeoversMay 5th, 2025
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
